The Prevalence and Related Factors of Diabetic Retinopathy in Shahroud
DOI:
https://doi.org/10.22100/jkh.v7i4.76Keywords:
Diabetic retinopathy, Diabetic Unit, Shahroud.Abstract
Introduction: Diabetic retinopathy is a dangerous complication of diabetes which can lead to blindness in these patients. The aim of the present study is to investigate and determine the prevalence of diabetic retinopathy in diabetic patients of Diabetes Unit of Shahroud.
Methods: This study is carried out on 625 clients of Diabetes Unit of Shahroud, during 10 years (since 1999-2002), patients were examined generally and ophthalmologicaly.
Results: The mean age of clients was 47.9±11.7 years. Mean age of diabetes contraction time was 48.5±53.8 months. In the fundoscopy 442 people were normal and 183 people (29.3%) were suffering from diabetic retinopathy, 23.4% of whom were non- proliferate type And 5.9% were proliferate type. A significant relationship was found between Diabetic retinopathy and age (P<0.05), diabetes type2 (P<0.003), and diabetes contraction time (P<0.003) and fasting blood sugar (P<0.008). However, no significant relationship was observed between gender (p=.062) and the antidiabetes drugs (P=0.58) and diabetic retinopathy
Conclusion: Considering accelerating factors of diabetic retinopathy, and timely diagnosis of diabetes mellitus and controlling the accelerating factors, we can decrease prevalence of this important complication of diabetes mellitus.
References
Abbasian M, Delvarian-Zadeh M. Evaluation of diabetes complications among the diabetic patients visiting the Shahroud diabetic. Knowledge & Health Journal 2008;10(4):16-20.[Persian].
Agardh EO, Torffvit CD. The prevalence of retinopathy and associated medical risk factor in type I (insulin-dependent) diabetic mellitus. J Int Med 2008;226:47-52.
Biswas A, Das K. A Bayesian analysis of bivariate ordinal data: wisconsin epidemiologic study of diabetic retinopathy revisited. Stat Med 2002;21:549-559.
Bustami R, Lesaffre E, Molenberghs G, Loos R, Danckaerts M, Vlietinck R. Modelling bivariate ordinal responses smoothly with examples from ophthalmology and genetics. Stat Med 2001;20:1825-1824.
Collins VR, Dowse GK, Plehwe WE, Imo TT, Toelupe PM, Taylor HR, et al. High prevalence of diabetic retinopathy and nephropathy in polynesians of Western Samoa. Diabetes Care 2005;18:1140-1149.
Emanuele N, Sacks J, Klein R, Reda D, Anderson R, Duckworth W, et al. Ethnically race and retinopathy correlates in the Veterans affairs diabetes trial. Diabetes Care 2005;28:1954-958.
Rafati N, Dehghan MH, Javadi MA, Souri H, Zaeri F, Gooya MM, et al. The prevalence of diabetic retinopathy in Tehran province. Bina J Ophthalmol 2008;13(2):166-175.[Persian].
Malekmadani MH. Lashay A, Behjati M, Ganji R. Frequency and severity of diabetic retinopathy in non-ocular diabetic complications. Tehran University Medical Journal 2007;65(7):58-63.[Persian].
Yarahmadi Sh, Larijani B, Bastanhagh MH, Pajouhi M, Baradar Jalili R, Zahedi F, et al. Metabolic and clinical effects of ramadan fasting in patients with type II diabetes. J Coll Physicians Surg Pak 2003;13(6):329-32.
Azimi-Nezhad M, Ghayour-Mobarhan M, Parizadeh MR, Safarian M, Esmaeili H, Parizadeh SM, et al. Prevalence of type 2 diabetes mellitus in Iran and its relationship with gender, urbanization, education, marital status and occupation. Singapore Med J 2008;49(7):571-576.
Stratton IM, Kohner EM, Aldington SJ, Turner RC, Holman RR, Manley SE, et al. UKPDS 50: risk factors for incidence and progression of retinopathy in type II diabetes over 6 years from diagnosis. Diabetologia 2004;44(2):156-163.
De Fine Olivarius N, Nielsen NV, Andreasen AH. Diabetic retinopathy in newly diagnosed middle-aged and elderly diabetic patients. Prevalence and interrelationship with microalbuminuria and triglycerides. Graefes Arch Clin Exp Ophthalmol 2001;239(9):664-672.
Larijani B, Zahedi F. Epidemiology of diabetes mellitus in Iran. Iranian Journal of Diabetes and Lipid disorders 2001;1(1):13-25.[Persian].
Janghorbani M, Amini M, Ghanbari H, Safaiee H. Incidence of and risk factors for diabetic retinopathy in Isfahan, Iran. Ophthalmic Epidemiol 2003;10(2):81-95.[Persian].
Meshkani R, Taghikhani M, Larijani B, Khatami S, Khoshbin E, Adeli K. The relationship between homeostasis model assessment and cardiovascular risk factors in Iranian subjects with normal fasting glucose and normal glucose tolerance. Clin Chim Acta 2006;371(1-2):169-75.
Saberi H, Mohammadtaghvaei N, Gulkho S, Bakhtiyari S, Mohammadi M, Hanachi P, et al. The ENPP1 K121Q polymorphism is not associated with type 2 diabetes and related metabolic traits in an Iranian population. Mol Cell Biochem 2011;350(1-2):113-8.
Meshkani R, Zargari M, Larijani B. The relationship between uric acid and metabolic syndrome in normal glucose tolerance and normal fasting glucose subjects. Acta Diabetol 2011;48(1):79-88.
Alavian SM, Hajarizadeh B, Nematizadeh F, Larijani B. Prevalence and determinants of diabetes mellitus among Iranian patients with chronic liver disease. BMC Endocr Disord 2004;4(1):4.
Pérez-Perdomo R, Pérez-Cardona C, Rodríguez-Lugo L. Prevalence of diabetes and patterns of health services utilization: a comparative analysis between a private and a health reform group of insured, 1997-1998. PR Health Sci J 2001;20(2):139-46.
Gonzalez Villalpando ME, Gonzalez Villalpando C, Arredondo Perez B, Stern MP. Diabetic retinopathy in Mexico. Prevalence and clinical characteristics. Arch Med Res 1994;25:355-60.
Fernando DJ, Siribaddana S, De Silva G, Subasinge Z. Prevalence of retinopathy in a Sri Lankan diabetes clinic. Ceylon Med J 1993;38:120-3.
Sparrow JM, McLeod BK, Smith TD, Birch MK, Rosenthal AR. The prevalence of diabetic retinopathy and maculopathy and their risk factors in the non-insulin-treated diabetic patients of an English town. Eye 1993;7:158-63.
Azizi F, Hadaegh F, Khalili D, Esteghamati A, Hosseinpanah F, Delavari A, et al. Appropriate definition of metabolic syndrome among Iranian adults: report of the Iranian national committee of obesity. Arch Iran Med 2010;13(5):426-8.
Ghazanfari Z, Niknami S, Ghofranipour F, Larijani B, Agha-Alinejad H, Montazeri A. Determinants of glycemic control in female diabetic patients: a study from Iran. Lipids Health Dis 2010;9:83.
Ebrahimpour P, Fakhrzadeh H, Heshmat R, Bandarian F, Larijani B. Serum uric acid levels and risk of metabolic syndrome in healthy adults. Endocr Pract 2008;14(3):298-304.
Klein R, Klein BE, Moss SE, Davis MD, DeMets DL. The wisconsin epidemiologic study of diabetic retinopathy. VI. Retinal photocoagulation. Ophthalmology 1987;94:747-53.
Newell SW, Tolbert B, Bennett J, Parsley TL. The prevalence and risk of diabetic retinopathy among Indians of southwest Oklahoma. J Okla State Med Assoc 1989;82:414-24.
West KM, Erdreich LJ, Stober JA. A detailed study of risk factors for retinopathy and nephropathy in diabetes. Diabetes 1980;29:501-8.
Klein R, Klein BE, Moss SE. Epidemiology of proliferative diabetic retinopathy. Diabetes Care 1992;15:1875-91.
El Haddad OA, Saad MK. Prevalence and risk factors for diabetic retinopathy among Omani diabetics. Br J Ophthalmol 1998;82:901-906.
Downloads
Published
Issue
Section
License
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
